Canadian Cancer Trials Group Bulletins

Group Administrators Office

Recent Publication

Canadian Cancer Trials Group MA.12 - Double-Blind Randomized Trial of Tamoxifen versus Placebo in Patients with Node Positive or High Risk Node Negative Breast Cancer Who Have Completed CMF, CEF or AC Adjuvant Chemotherapy

Chapman JA, Nielsen T, Ellis M, Bernard P, Chia S, Gelmon K, Pritchard K, Maitre A, Goss P, Leung S, Shepherd L, Bramwell V. Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in Canadian Cancer Trials Group MA.12 Trial and BC Cohort. Breast Cancer Research 15: R71, 2013.